Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
James S. Hanson Insider Profile
4 Followers
James S. Hanson, General Counsel at G1 Therapeutics, holds 7.50K shares in Fortrea Holdings Inc. (Ticker: FTRE), holds 41.09K shares in G1 Therapeutics (Ticker: GTHX). Most recently, James S. Hanson Bought ― shares of Fortrea Holdings Inc. on Jun 12, 2024 for an estimated value of 50.60K.
James S. Hanson G1 Therapeutics (GTHX)General Counsel
G1 Therapeutics (GTHX)
General Counsel
Ranked #16,873 out of 99,335 Corporate Insiders
Profitable Transactions
3 out of 6 Profitable Transactions
Average Return
+16.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of James S. Hanson's holdings
Insider Roles
GC
Roles that James S. Hanson holds in companies
Most Profitable Insider Trade
Stock:
G1 Therapeutics
(GTHX)
(GTHX)
Rating:Informative Sell
Date:Jan 05, 2022 - Jan 05, 2023
Return:+48.70%
The most profitable trade made by James S. Hanson
James S. Hanson's Trading History
G1 Therapeutics
Jan 05, 2023
―
Uninformative Buy
―
$293.77K
Fortrea Holdings Inc.
Jun 12, 2024
GC
Informative Buy
50.60K
$147.97K
List of latest transactions for each holding click on a transaction to see James S. Hanson's performance on stock
You May Also Like
James S. Hanson insider profile FAQ
What is the percentage of profitable transactions made by James S. Hanson?
The percentage of profitable transactions made by James S. Hanson is 50%.
What is the average return per transaction made by James S. Hanson?
The average return per transaction made by James S. Hanson is 16.30%.
What stocks does James S. Hanson hold?
James S. Hanson holds: GTHX, FTRE stocks.
What was James S. Hanson’s latest transaction?
James S. Hanson latest transaction was an Informative Buy of $50.60K.
What was James S. Hanson's most profitable transaction?
James S. Hanson’s most profitable transaction was an Informative Sell of GTHX stock on January 5, 2022. The return on the trade was 48.70%.
What is James S. Hanson's role in G1 Therapeutics?
James S. Hanson's role in G1 Therapeutics is General Counsel.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.